Direct-current plasma emission spectrometry determines food calcium and phosphorus, faecal calcium and chromium, and urinary calcium and phosphorus accurately, precisely and rapidly without acid digestion or dry ashing. Food and faeces are homogenised, diluted and aspirated directly into the plasma. The method makes metabolic balances swifter and less labour-intensive; it enables the use of chromium sesquioxide as an inert marker, for perchlorate digestion is avoided. Both plasma emission (-9'9%) and a dry ashing procedure (-13·5%) give lower values for food phosphorus than those derived from food tables.
Calcium balances are important in the investigation of metabolic bone disease and in studying the effects of drugs and physiological substances, such as hormones, upon bone. Such studies require careful analysis of calcium in food, faeces and urine. The analytical techniques commonly used are laborious, tedious and time-consuming and require, for food and faeces, dry ashing and heating to 400°C before analysis by atomic absorbance spectrometry.
Collection of the faecal output has to be carefully controlled, usually by the inclusion of an inert marker. Rose I showed that the relatively inert marker, chromium sesquioxide, was one of the most satisfactory and from 1969 to 1978 this technique was used in our department. Unfortunately, perchlorate digestion of the sesquioxide to the dichromate is now not recommended because of the formation of explosive perchlorates.
The recent introduction of plasma emission spectrometers/ enables the analysis of a wide number of elements in physiological fluids with the minimum of sample preparation. 3. 4 We now report our findings on the use of a DC plasma emission system, for the analysis of calcium, phosphorus and chromium in metabolic balance studies, and compare the results with previously accepted techniques.
Materials and methods
All reagents were analytical grade and obtained from British Drug Houses, Ltd, Poole, Dorset, UK (B.D.H.). Solutions were prepared in doubly deionised water ('Spectrum System', Elga Products Ltd, High Wycombe, Bucks, UK). Chromium sesquioxide was supplied in gelatin capsules, each containing 250 mg, by the Pharmacy Department of the Royal Liverpool Hospital, and was used subsequently as the analytical primary standard. The calcium standard was the calcium standard solution, atomic absorbance grade (B.D.H.). Primary standard phosphorus solutions were prepared from dry sodium dihydrogen orthophosphate (B.D.H.).
Metabolic balance studies were carried out in the Metabolic Ward on patients maintained on a fixed diet. On starting the diet, patients were given two 250 mg capsules of chromium sesquioxide three times daily with main meals. Stool collections for the balance study commenced after the voiding and discarding of two consecutive stools in which the green chromium sesquioxide was seen on inspection to be thoroughly mixed, provided that at least 3 full days had elapsed. The balance study was then continued for 4 to 9 days, depending on individual circumstances. Two separate, complete daily intakes of food were homogenised using either a Waring blender (Townson and Mercer Ltd, Croydon, UK) or Virtis homogeniser (Virtis Co, Gardiner, New York, USA) and made up to a volume of either 2 or 3 litres with deionised water. The faecal collections were homogenised and mixed to a final volume of 2 or 3 litres with deionised water. Twenty-four-hour urine collections were made throughout the period of study.
Atomic absorbance determination of calcium was carried out on an SP 1900 spectrophotometer (Pye Unicam, Cambridge, UK) using the procedure of Pybus." Food and faeces were dry ashed at 400°C. Urinary inorganic phosphorus was analysed by a phosphomolybdate colorimetric procedure incorporated into the SMAC (Technicon Instruments Ltd, New York, USA). Faecal chromium was measured as the dichromate after perchlorate digestion. h Calcium and phosphorus contents of the duplicate meals were also calculated from food tables." PLASMA EMISSION PROCEDURES Spectraspan III (Beckman-RIlC, High Wycombe, UK) is a DC argon plasma spectrometer in which plasma is generated between two carbon anodes and a tungsten cathode with a 2·0 l/rnin argon flow. The elemental emissions are resolved by an Echelle Spectrometer between 190--800 nm over 90 orders. The instrumental conditions were optimised for each element to be analysed and the sample was aspirated at approximately 2·0 ml/rnin and introduced to the plasma as an aerosol, by nebulisation through a crossed flow nebuliser and argon carrier gas at 7 I/min. The sample in the region of excitation, the so-called 'fire-ball region', was analysed over 20--30 sec using two or three analysis integration periods each of 10 sec. The entrance and exit slits through the spectrometer were set at 500 11m horizontally and 200 11m vertically. The instrument was calibrated for each element under the conditions given in Table 1 and the concentrations of the suspensions computed directly by the instrument in the same units as the standards.
Aliquots of the food and faecal homogenates were diluted 1:10 in 1% HNO] and then 1: 10 in 1% v/v HNO] containing 1·0 mol/l LiNO] before direct aspiration into the plasma. Urine was diluted, before aspiration, 1 to 20 with the strontium chloride diluent (19 g strontium chloride, 45 ml perchloric acid in 5 I H 20) and/or with 1% v/v HNO] in 1·0 M LiNO] for plasma emission analysis. Both parametric and non-parametric statistical analyses (Spearman rank test) were applied to the data, as appropriate.
Lithium was added in the final diluent in order to minimise any possible enhancement by alkali metals, e.g. Na, of the emission under investigation. Table 2 indicates that there is little, if any, matrix interference in the analysis of calcium and phosphorus in food or faeces, or of chromium in faeces. The analysis is also shown to be reproducible and precise. Urine analysis of calcium (Table 3 ) and phosphorus ( Fig. 1) would also indicate no matrix ion interference.
Results

CALCIUM IN FOOD, FAECES AND URINE
Direct comparison of the analysis of calcium in faeces and urine by plasma emission and atomic absorbance is shown in 
CV=coefficient of variation analysis indicates there is no significant difference between the two methods throughout the entire range assayed. For calcium in food, compared with calculation from food tables, a similar highly significant degree of correlation was observed (Table 4 ).
PHOSPHORUS IN FOOD, FAECES AND URINE
Direct comparison of total food phosphorus analysis by plasma emission with values calculated from food tables shows a close correlation, although the mean obtained by plasma emission appears to be of the order of 10% lower (Table 4 ). Comparative analysis of inorganic phosphorus in urine with a standard chemical procedure showed excellent agreement ( Fig. 1 ).
CHROMIUM AS THE SESQUIOXIDE IN FAECES
A comparison between plasma emission and colorimetric chromium assay, gave a good correlation albeit with a reduced degree of statistical significance, when compared with calcium and phosphorus analyses (Fig. 2 ).
Discussion
The value of an analytical method is determined by accuracy, precision, sensitivity and ease of manipulation. We have now shown that use of the DC plasma spectrometer for the analysis of calcium, phosphorus and chromium fulfils these criteria and the instrument can handle the widely differing matrices of foods, faeces and urine without apparent interference from other accompanying elements. This new procedure therefore negates the need either for dry ashing in muffle furnaces or acid digestion when carrying out metabolic balance studies for these elements.
The results of the food phosphorus analyses suggest that most, if not all, of the organophosphates are destroyed in the high temperature plasma (analytical excitation temperature > 6000 0K) to allow phosphorus atomic emissions to occur. The slightly lower values by plasma emission analysis may indicate differences in the actual phosphorus available, inefficient homogenisation of cellular organelles or indeed a lower phosphorus content. Inefficient homogenisation is thought unlikely, as the food calcium analyses agreed very well with the food tables (Table 3 ). However, phosphorus analysis by plasma emission in urine agrees well with the chemical assay, and thus offers an alternative to the well-established SMAC auto-analytical procedure.
In order to investigate further the differences between the food table values for food phosphorus and those determined by plasma emission we have compared, retrospectively, the food table phosphorus values with the analytical values obtained, (after dry ashing and complexing with phosphomolybdate followed by reduction), in patients with primary hyperparathyroidism in whom balance studies were carried out before plasma emission was available. The mean value from food tables for 16 patients was 36·3±7·3 (SD) mmollday and for the analytical method, 31·4±6·5 mmoVday. The correlation coefficient was +0·90. The analytical method thus gave values 13·5% less than the food tables, whereas with plasma emission the mean difference was 9·9%. It seems therefore that plasma emission is giving values close to the earlier analytical method that preceded it, and close to the unreduced phosphomolybdate method used on the SMAC auto-analyser. (Table 4 ). It should be noted that the food table phosphorus was determined by a dry ashing followed by formation of a reduced phosphomolybdate complex, using hydroquinone and sodium sulphite, yet one of us has found the reduced and unreduced phosphomolybdate techniques to give closely similar values."
Chromium sesquioxide has been used as an inert marker in many balance studies and is preferred over the polyethlyene glycol or Carmine Red markers. To overcome the hazards of 'wet' analysis Hesp et al.9 recently suggested the use of 51Cr-labelled CrCI]. However, use of radioactive compounds may present with as many problems in handling, use and disposal, to both patient and staff. Thus, the now reported application to chromium analysis by plasma emission has enabled the reintroduction in our metabolic ward of a wellestablished inert marker for metabolic balance studies. It has been reported that chromium, as the sesquioxide, is hardly absorbed from the gastrointestinal tract of a variety of patients; 10 it may be possible because of the sensitivity of the assay to reduce further any risk of chromium absorption by decreasing the dosage of chromium sesquioxide.
The elements analysed in this study are present in relatively high concentrations and thus high dilution of the initial homogenate before analysis is possible. For the analysis of the 'trace elements' in metabolic bone disease, e.g. strontium, or zinc, lower dilution will be necessary and the analytical determinant may well then be the homogenisation procedure to give a consistent emulsion of sufficiently small particle size. Fortunately, the configuration of the DC plasma, unlike the inductively coupled plasmas, allows aspiration of samples with 20%
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(w/v) solid content, including whole blood. Thus, this technique might offer considerable scope in investigating other 'element balances' in bone disease.
